Redeye comments on Freemelt’s new order from Saab Dynamics.
Redeye gives an additional comment on the written minutes from the FDA following the end of phase II...
ChargePanel AB (”ChargePanel” eller ”Bolaget”) har under helåret 2023 uppvisat en hög aktivitet geno...
Smart Eye’s CEO Martin Krantz and CFO Mats Benjaminsson presented the background and purpose of the ...
IRLAB Therapeutics has confirmed the FDA’s alignment with its proposed Phase III programme for mesdo...
Redeye has commented on BeammWave's capital raise, which aims to secure SEK39.
On Friday, TH1NG announced the divestment of its broadband customers to Bahnhof.
Redeye gives its estimate changes in Smart Eye following the recent news flow in the company.
Adj. EBITDA of GBP 2m in line with pre-annoucement (ABGSCe 3m) We trim sales but raise '24e EBIT fro...
Redeye updates its view on CI Games post its release of Lords of the Fallen.
FDA aligns with Ph 3 design presented at IRLAB's 2023 CMD Design compatible with earlier Ph 2b, to c...
Redeye endorses the outcome of IRLAB’s end of phase II meeting with the FDA, including the recently ...
Huddlestock announced on Friday, March 22nd, that the company's client Stackby.
Earlier today, Coala-Life announced the board’s decision to file for bankruptcy.
Redeye provides its initial comments following Smart Eye’s directed share issue of SEK150m, announce...
Pharma Equity Group (“PEG” or “the Company”) presented a Q4-report marked by advancements in the cli...
Nytt obligationslån Vi återupptar vår bevakning av Orexo efter att bolaget emitterat ett nytt säkers...
Cibus announced yesterday evening it has issued a 4-year EUR bond of EUR 80m at Euribor 3m plus 400b...
A diversified M&A play on civic infrastructure 1) Rapid growth, 2) deleveraging, 3) 15% growth & 12%...
37% y-o-y ARR growth with 118% NRR in Q4 Lifting '24e-'26e ARR by 6-8%, EBITDA largely unchanged New...
